Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Clinical trial NCT00735371 · COMPLETED

Trial details

NCT number: NCT00735371
Sponsor: Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder (ADHD)

Start date: 2008-10-08
Primary completion: 2009-04-06
Enrollment: 314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.